Sector Alpha

Track where the smart money flows in Indian equities

DashboardWeekly UpdateUploadPipelinePE CyclesBrainAbout

Data updated weekly. Not financial advice.

Sector Alpha
  1. Home
  2. /Deep Value
  3. /Chemicals - Others
  4. /S H Kelkar & Company Ltd
MomentumDeep Value

S H Kelkar & Company Ltd: Is It a Deep Value Opportunity?

AverageAccelerating

As of Mar 28, 2026, S H Kelkar & Company Ltd (Chemicals - Others) has a deep value score of 51/100 (rated Average). Earnings are accelerating. 1Y return vs Nifty 500: -32%.

PE: Mid ExpansionStrong Opportunity

What's Happening

💎PE falling while earnings hold — value emerging
👔Promoter stake down 0.8% this quarter
🌐FII stake decreased 2.0% this quarter
🏛️DII accumulation — stake up 3.4%
💰Trading 77% below estimated fair value — significant discount

Re-Rating Catalysts

1. Margin recovery to 12%+ OPM by Q4 FY26
Q4 FY26 (Mar 2026)MEDIUM
2. Debt reduction to D/E of 0.5x by Q1 FY27
Q1 FY27 (Jun 2026)MEDIUM
3. US market contribution reaching 15% of revenue
Q2 FY27 (Sep 2026)LOW

Value Trap Risks

1. Persistent margin pressure in specialty chemicals
HIGH
2. Working capital trap limiting financial flexibility
MEDIUM

Key Numbers

PAT Growth YoY
+83%
Stable
Revenue YoY
+8%
Stable
Operating Margin
9.0%
-300 bps YoY
PE Ratio
17.8
PEG Ratio
2.89
Current Price
₹119
Dividend Yield
0.84%
3Y PAT CAGR
-21%
Market Cap
1.7K Cr
Valuation
Significantly Undervalued

Is S H Kelkar & Company Ltd a Turnaround Opportunity?

Deep value thesis based on recent earnings • Updated Mar 7, 2026

S H Kelkar is showing early signs of recovery with revenue growth accelerating to 7.5% YoY in Q3 FY26 (₹583.8 crore), PBT surging 79.2% YoY to ₹49 crore, and a dramatic 449.5% YoY improvement in 9M PBT to ₹97.8 crore, driven by margin recovery initiatives and strategic investments in global markets that could unlock value as operational efficiencies materialize.

Verdict

EARLY_INNINGS

What Could Re-Rate S H Kelkar & Company Ltd?

Re-rating catalysts over the next 2-4 quarters • Updated Mar 7, 2026

Margin recovery to 12%+ OPM by Q4 FY26

Expected: Q4 FY26 (Mar 2026)MEDIUM confidence

Cost optimization initiatives expected to reverse 229 bps YoY margin compression, targeting OPM expansion to 12%+ by year-end

“Management commentary on financial discipline and working capital efficiency in Q3 earnings call”

Debt reduction to D/E of 0.5x by Q1 FY27

Expected: Q1 FY27 (Jun 2026)MEDIUM confidence

Improved cash flows from operational turnaround expected to reduce D/E from current 0.67x to 0.5x within 6 months

“G CFO's statement on strengthening financial discipline and improving cash conversion”

US market contribution reaching 15% of revenue

Expected: Q2 FY27 (Sep 2026)LOW confidence+₹87.5 Cr revenue

Strategic US expansion expected to drive premium valuation as global footprint diversifies revenue base

Impact: +₹87.5 Cr revenue

“Management's focus on long-term strategy and global footprint expansion mentioned in Q3 results”

What Are the Value Trap Risks for S H Kelkar & Company Ltd?

Risks that could prevent re-rating or deepen the value trap

Persistent margin pressure in specialty chemicals

HIGH

Continued input cost inflation or pricing pressure in specialty chemicals sector

Impact: -200 bps margin impact

Management view: Management acknowledges margin pressures but believes cost optimization will reverse trend by Q4 FY26

Monitor: Quarterly OPM trend and input cost data

Working capital trap limiting financial flexibility

MEDIUM

Further inventory buildup or receivables deterioration

Management view: Management focusing on working capital efficiency as stated in Q3 earnings call

Monitor: Operating cash flow to revenue ratio and DSO/DIO trends

What Is S H Kelkar & Company Ltd's Management Guidance?

Forward-looking targets from management for FY27

Revenue Growth Target

10%

Implied PAT Growth

35%

OPM Guidance

12%

Capex Plan

₹150 Cr

Management Tone: CAUTIOUS

Key Milestones

• Margin recovery to 12%+ OPM by Q4 FY26

• US market contribution reaching 15% of revenue by Q2 FY27

How Fast Is S H Kelkar & Company Ltd Growing?

Revenue, profit and margin growth rates

MetricYoY3Y CAGRTrend
Revenue+8%+11%Stable
PAT (Net Profit)+83%-21%Stable
OPM9.0%-300 bpsVolatile

The above analysis is AI-generated from publicly available financial data. This is educational research only — not investment advice. Last updated Mar 7, 2026.

Other Deep Value Stocks in Chemicals - Others

Camlin Fine Sciences Ltd
Very Weak
10
← Back to Chemicals - OthersAll Deep Value SectorsDashboard

Frequently Asked Questions: S H Kelkar & Company Ltd

Based on publicly available financial data. This is educational research, not investment advice.

What is S H Kelkar & Company Ltd's deep value score?

S H Kelkar & Company Ltd has a deep value score of 51/100 (rated Average). This score is calculated from three components

  • Earnings Score: 30/40 — measures PAT growth momentum across quarters
  • Underperformance Score: 20/35 — how much the stock trails Nifty 500 (deeper underperformance = higher contrarian signal)
  • Quality Score: 12/25 — operational quality (margins, revenue growth, valuation)

Is S H Kelkar & Company Ltd fundamentally improving?

S H Kelkar & Company Ltd's quarterly profit (PAT) growth trajectory

  • Latest Quarter PAT Growth (QoQ): +256%
  • Previous Quarter PAT Growth (QoQ): -64%
  • 2 Quarters Ago PAT Growth (QoQ): -75%
  • PAT Acceleration: +165.5pp (profits are accelerating)
  • 1 consecutive quarters of positive PAT growth

Why is S H Kelkar & Company Ltd underperforming despite good earnings?

S H Kelkar & Company Ltd is underperforming the market despite improving earnings — this is the core deep value thesis

  • 1-Year Return vs Nifty 500: -32%
  • 6-Month Return vs Nifty 500: -41%
  • 3-Month Return vs Nifty 500: -22%
  • Yet average quarterly PAT growth is +39% — earnings are improving
  • The market often takes time to re-rate stocks with improving fundamentals. This gap between price performance and earnings improvement is what deep value research seeks to identify.

What is the earnings momentum for S H Kelkar & Company Ltd?

S H Kelkar & Company Ltd's earnings momentum is Accelerating — profit growth is speeding up.

  • PAT QoQ progression: -75% → -64% → +256% (2Q ago → 1Q ago → latest)
  • Acceleration: +165.5pp
  • PAT YoY Growth: +83%

Is S H Kelkar & Company Ltd undervalued?

S H Kelkar & Company Ltd's valuation metrics

  • Price-to-Earnings (PE): 9.7x
  • Price-to-Book (PB): 1.2x
  • PEG Ratio: 2.9x
  • Margin of Safety: +77% (appears undervalued)

What are the revenue and margin trends for S H Kelkar & Company Ltd?

S H Kelkar & Company Ltd's revenue and margin trends

  • Latest Quarter Revenue Growth (QoQ): +5%
  • Average Quarterly Revenue Growth: +1%
  • Revenue Acceleration: +1.5pp
  • Latest OPM Change: +0.1pp (margins expanding)
  • Average OPM Change: -1.1pp
  • Revenue YoY: +8%

What is S H Kelkar & Company Ltd's trailing twelve month (TTM) performance?

S H Kelkar & Company Ltd's trailing twelve month (TTM) performance

  • TTM PAT: ₹171 Cr
  • TTM PAT Growth: +100.0% YoY
  • TTM Revenue: ₹2,000 Cr
  • TTM Revenue Growth: +10.5% YoY
  • TTM Operating Margin: 11.0%

What sector does S H Kelkar & Company Ltd belong to?

S H Kelkar & Company Ltd key facts

  • Sector: Chemicals - Others
  • Market Cap: ₹1.7K Cr
  • Rank in Chemicals - Others: #1 by value score
  • Overall rank among all deep value stocks: #35

Is S H Kelkar & Company Ltd a good deep value opportunity to study?

S H Kelkar & Company Ltd shows limited deep value signals currently — score is 51/100 (Average). Monitor for improvement.

  • Value Score: 51/100 (Average)
  • Earnings: Accelerating
  • 1Y Underperformance: -32% vs Nifty 500

What is the bull and bear case for S H Kelkar & Company Ltd?

Research Signals (Bull Case)

  • Earnings accelerating — profit growth speeding up
  • Appears undervalued based on fair value analysis
  • Revenue growth also accelerating

Risk Factors (Bear Case)

  • Significant underperformance (-32% vs Nifty 1Y)
  • Margin pressure warning
  • Operating margins contracting

Which other Chemicals - Others stocks are deep value opportunities?

Other deep value stocks in Chemicals - Others

  • Camlin Fine Sciences Ltd — Score 10/100, Very Weak

How does the Chemicals - Others sector look for deep value?

Chemicals - Others deep value sector overview

  • 1 deep value stocks in this sector
  • Average value score: 31/100
  • Avg PAT acceleration: +165.5pp
  • Top pick: S H Kelkar & Company Ltd

What is deep value investing?

Deep value investing studies stocks that are underperforming the market despite showing improving fundamentals. The thesis is that the market has not yet recognized the earnings recovery, creating a potential valuation gap. It requires patience — recovery can take several quarters.

How is the deep value score calculated?

The deep value score (0-100) combines three factors:

- Earnings (0-40 pts): PAT growth across last 3 quarters, acceleration, and consecutive growth - Underperformance (0-35 pts): How much the stock trails Nifty 500 over 1Y, 6M, 3M (deeper underperformance = higher score) - Quality (0-25 pts): Revenue growth, margin trends, and valuation metrics (PEG, P/B)

Higher score indicates a stronger contrarian research signal.

What are the growth catalysts for S H Kelkar & Company Ltd?

S H Kelkar & Company Ltd has 3 key growth catalysts identified from recent earnings analysis

  • Margin recovery to 12%+ OPM by Q4 FY26
  • Debt reduction to D/E of 0.5x by Q1 FY27
  • US market contribution reaching 15% of revenue

What are the key risks in S H Kelkar & Company Ltd?

S H Kelkar & Company Ltd has 2 key risks worth monitoring

  • Persistent margin pressure in specialty chemicals
  • Working capital trap limiting financial flexibility

The above FAQs are generated from publicly available earnings data. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.